Annual CFF:
$250.88M+$157.66M(+169.11%)Summary
- As of today, VRNA annual cash from financing is $250.88 million, with the most recent change of +$157.66 million (+169.11%) on December 31, 2024.
- During the last 3 years, VRNA annual cash from financing has risen by +$257.00 million (+4201.90%).
- VRNA annual cash from financing is now at all-time high.
Performance
VRNA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$5.05M-$8.46M(-62.62%)Summary
- As of today, VRNA quarterly cash from financing is $5.05 million, with the most recent change of -$8.46 million (-62.62%) on June 1, 2025.
- Over the past year, VRNA quarterly cash from financing has dropped by -$161.47 million (-96.97%).
- VRNA quarterly cash from financing is now -97.33% below its all-time high of $189.18 million, reached on September 30, 2020.
Performance
VRNA Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$105.68M-$161.47M(-60.44%)Summary
- As of today, VRNA TTM cash from financing is $105.68 million, with the most recent change of -$161.47 million (-60.44%) on June 1, 2025.
- Over the past year, VRNA TTM cash from financing has dropped by -$82.06 million (-43.71%).
- VRNA TTM cash from financing is now -60.44% below its all-time high of $267.15 million, reached on March 31, 2025.
Performance
VRNA TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VRNA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +169.1% | -97.0% | -43.7% |
| 3Y3 Years | +4201.9% | +837.6% | +2664.4% |
| 5Y5 Years | +100.0% | +100.0% | -44.1% |
VRNA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +4201.9% | -97.0% | +178.5% | -60.4% | +399.4% |
| 5Y | 5-Year | at high | +4201.9% | -97.3% | +178.5% | -60.4% | +1645.5% |
| All-Time | All-Time | at high | +4201.9% | -97.3% | +178.5% | -60.4% | +1645.5% |
VRNA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.05M(-62.6%) | $105.68M(-60.4%) |
| Mar 2025 | - | $13.51M(-85.6%) | $267.15M(+6.5%) |
| Dec 2024 | $250.88M(+169.1%) | $93.56M(+1554.1%) | $250.88M(+38.3%) |
| Sep 2024 | - | -$6.43M(-103.9%) | $181.39M(-3.4%) |
| Jun 2024 | - | $166.52M(+6138.9%) | $187.74M(+787.1%) |
| Mar 2024 | - | -$2.76M(-111.5%) | $21.16M(-77.3%) |
| Dec 2023 | $93.23M(-33.8%) | $24.07M(>+9900.0%) | $93.23M(+27.5%) |
| Sep 2023 | - | -$83.40K(-30.9%) | $73.11M(-65.4%) |
| Jun 2023 | - | -$63.70K(-100.1%) | $211.38M(+0.3%) |
| Mar 2023 | - | $69.31M(+1655.3%) | $210.76M(+49.8%) |
| Dec 2022 | $140.73M(+2400.9%) | $3.95M(-97.1%) | $140.73M(+3.6%) |
| Sep 2022 | - | $138.19M(>+9900.0%) | $135.89M(+3397.4%) |
| Jun 2022 | - | -$684.60K(+5.2%) | -$4.12M(+39.7%) |
| Mar 2022 | - | -$721.80K(+18.7%) | -$6.84M(-11.8%) |
| Dec 2021 | -$6.12M(-103.2%) | -$888.30K(+51.4%) | -$6.12M(-17.0%) |
| Sep 2021 | - | -$1.83M(+46.3%) | -$5.23M(-102.8%) |
| Jun 2021 | - | -$3.40M(>-9900.0%) | $185.78M(-1.8%) |
| Mar 2021 | - | $0.00(-100.0%) | $189.18M(+0.1%) |
| Dec 2020 | $193.84M(>+9900.0%) | - | - |
| Sep 2020 | - | $189.18M(>+9900.0%) | $189.02M(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | -$319.30K(+25.6%) |
| Mar 2020 | - | $0.00(+100.0%) | -$429.00K(+20.3%) |
| Dec 2019 | $0.00 | -$159.10K(+0.7%) | -$538.40K(-41.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$160.20K(-46.0%) | -$379.30K(-73.1%) |
| Jun 2019 | - | -$109.70K(-0.3%) | -$219.10K(-100.3%) |
| Mar 2019 | - | -$109.40K(>-9900.0%) | -$109.40K(>-9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $0.00(0.0%) | $292.90K(-76.5%) |
| Jun 2018 | - | $0.00(0.0%) | $1.25M(-98.5%) |
| Mar 2018 | - | $0.00(-100.0%) | $85.22M(+1.6%) |
| Dec 2017 | $81.45M(+46.5%) | $292.90K(-69.2%) | $83.90M(+0.4%) |
| Sep 2017 | - | $952.10K(-98.9%) | $83.60M(+1.2%) |
| Jun 2017 | - | $83.97M(+6455.3%) | $82.65M(+6355.3%) |
| Mar 2017 | - | -$1.32M | -$1.32M |
| Dec 2016 | $55.60M(>+9900.0%) | - | - |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Dec 2014 | $21.57M(+664.2%) | - | - |
| Dec 2013 | $2.82M(+74.7%) | - | - |
| Dec 2012 | $1.62M(-52.7%) | - | - |
| Dec 2011 | $3.42M(+153.2%) | - | - |
| Dec 2010 | $1.35M(-57.2%) | - | - |
| Dec 2009 | $3.15M(-29.7%) | - | - |
| Dec 2008 | $4.49M(>+9900.0%) | - | - |
| Dec 2007 | $0.00(-100.0%) | - | - |
| Dec 2006 | $3.17M(+83.3%) | - | - |
| Dec 2005 | $1.73M | - | - |
FAQ
- What is Verona Pharma plc annual cash from financing?
- What is the all-time high annual cash from financing for Verona Pharma plc?
- What is Verona Pharma plc annual cash from financing year-on-year change?
- What is Verona Pharma plc quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Verona Pharma plc?
- What is Verona Pharma plc quarterly cash from financing year-on-year change?
- What is Verona Pharma plc TTM cash from financing?
- What is the all-time high TTM cash from financing for Verona Pharma plc?
- What is Verona Pharma plc TTM cash from financing year-on-year change?
What is Verona Pharma plc annual cash from financing?
The current annual cash from financing of VRNA is $250.88M
What is the all-time high annual cash from financing for Verona Pharma plc?
Verona Pharma plc all-time high annual cash from financing is $250.88M
What is Verona Pharma plc annual cash from financing year-on-year change?
Over the past year, VRNA annual cash from financing has changed by +$157.66M (+169.11%)
What is Verona Pharma plc quarterly cash from financing?
The current quarterly cash from financing of VRNA is $5.05M
What is the all-time high quarterly cash from financing for Verona Pharma plc?
Verona Pharma plc all-time high quarterly cash from financing is $189.18M
What is Verona Pharma plc quarterly cash from financing year-on-year change?
Over the past year, VRNA quarterly cash from financing has changed by -$161.47M (-96.97%)
What is Verona Pharma plc TTM cash from financing?
The current TTM cash from financing of VRNA is $105.68M
What is the all-time high TTM cash from financing for Verona Pharma plc?
Verona Pharma plc all-time high TTM cash from financing is $267.15M
What is Verona Pharma plc TTM cash from financing year-on-year change?
Over the past year, VRNA TTM cash from financing has changed by -$82.06M (-43.71%)